Dear visitor

It looks like you want to view this
website in a different language.

Please click here to view this website in English.

KNCV believes in a human rights and patient-centered approach, which warrants innovative, practical and effective tools and interventions to optimize diagnosis and treatment for all. Unfortunately, the experience to date with the introduction of new diagnostic tools, drugs and treatment regimens shows insufficient preparedness of countries and national TB programs for the rapid uptake and scale-up of these innovations.

KNCV’s ‘Patient Triage’ approach

KNCV’s initiative on ‘Right Diagnosis, Right Treatment’ aims to accelerate the processes required for piloting, adoption, implementation, evaluation and scale-up of successful interventions. At its core is KNCV’s ‘Patient Triage’ approach. This promotes access to new drugs and regimens coupled with rapid, specific molecular tests to detect TB and various forms of drug-resistant TB. It offers early and correct ‘triaging’ of patients to the least toxic, shortest, most appropriate and effective regimen, without the risk of creating more drug-resistance.

Read more about this

The concept of right diagnosis right treatment has benefits at all levels

  • Patients

    • Early treatment
    • Lowest side effects
    • Improved quality of live
  • Health systems

    • Less costly treatments
    • Easier to administer
    • Better treatment rates
  • Public health

    • Reduce risk transmissions
    • Reduce DR-TB
    • Revert the TB burden

How KNCV helps

By now KNCV has helped with the successful implementation of new drugs and shorter treatment regimen in 21 countries. We had to wait for 40 years for new TB drugs, let’s not loose time to use these!

“The journey to saving lives is tough, tortuous and challenging, yet very rewarding. Many lives of individuals and families have been saved from TB or its catastrophic impact. We are not there yet, and a lot still needs to be done to reach all the missing TB cases, but we are making appreciable progress.”

Dr. Gidado Mustapha, Director of the USAID funded global Challenge TB project